PAN: Breast Cancer (Medicare)

Not Funded
About
The PAN: Breast Cancer (Medicare) program provides comprehensive assistance for breast cancer patients enrolled in Medicare, covering an extensive list of drug products including Abraxane, Afinitor, and many others. PAN: Breast Cancer (Medicare) ensures fast eligibility determination, allowing immediate access to critical treatments. Patients in the United States can benefit from coverage of eligible expenses, efficient renewal processes, and potential reimbursement for out-of-pocket costs, making PAN: Breast Cancer (Medicare) a valuable resource for managing medication expenses.
Insurance requirements: Medicare / Medicaid
Enrollment Forms
Enrollment Form
Benefits
$2000 annual maximum benefit
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
Please note the following:
1. This fund may cover offlabel drugs
Provided patient completes application on self service portal or over the phone, eligibility determination takes less than one minute
Portal/representative will provide enrollment dates, the patient's PAN I.D. number and the available grant balance, allowing for medications to be dispensed
Patients will also receive approval letter and plastic pharmacy card within one week (provider will also receive letter)
Assistance begins on approval date and continues for 12 months
During initial eligibility period, eligible expenses incurred up to 90 days prior to approval date may also be submitted for reimbursement
All eligible expenses must be submitted within 120 days of the eligibility end date
Payment can be made to the patient, physician, pharmacy or health care provider
Patients are eligible for renewal at the end of their eligibility period if funds are available
Foundation will send a renewal application automatically if the program is accepting renewal patients
Patient may apply for a second grant during their eligibility period subject to availability of funding
Diagnosis Codes: ICD10: C50.011, C50.012, C50.019, C50.021, C50.022, C50.029, C50.111, C50.112, C50.119, C50.121, C50.122, C50.129, C50.211, C50.212, C50.219, C50.221, C50.222, C50.229, C50.311, C50.312, C50.319, C50.321, C50.322, C50.329, C50.411, C50.412, C50.419, C50.421, C50.422, C50.429, C50.511, C50.512, C50.519, C50.521, C50.522, C50.529, C50.611, C50.612, C50.619, C50.621, C50.622, C50.629, C50.811, C50.812, C50.819, C50.821, C50.822, C50.829, C50.911, C50.912, C50.919, C50.921, C50.922, C50.929, D05.00, D05.01, D05.02, D05.10, D05.11, D05.12
Other Programs

Assistance Fund: Prostate Cancer

Commercially Insured
Medicare / Medicaid

Assistance Fund: Prostate Cancer: Waitlist

Commercially Insured
Medicare / Medicaid
Other Tools for Eligard